Rejive Dayanandan
Senior Clinical Trial Manager
Rejive joined the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in 2001, initially working on the SEARCH trial as a study administrator during the latter stages of recruitment.
He is currently one of the CTSU representatives on the Oxford Clinical Trials Units Operational Leads Group and the administrative co-lead on the EASi-KIDNEYTM.
He was involved in the setting up of sites in the UK region of HPS2-THRIVE trial to assist with the completion of recruitment and subsequently took on the role of Senior Clinical Trial Manager overseeing all administrative aspects of the international REVEAL trial within the UK region.
He was the lead administrator on the UK HARP-III trial and shortly after completion of that UK-based trial, was responsible for oversight of trial administration of the international EMPA-KIDNEY trial.